Overview of brain diseases

September 26, 2018

Disorders of the peripheral and central nervous system are very severe in nature. They may lead to the complete degeneration of the neurological system and permanently incapacitate an individual. These disorders are observed mainly after the age of 65. But in recent years, young adults and even small children are being diagnosed with neurological diseases. The most common form of the neurological disease is “brain diseases” that is affecting the lives of millions worldwide. According to the global estimates by the World Health Organization, 1 out of every 6 people in any country suffers from one or the other type of brain disease. This has resulted in reduced life expectancy all over the world and demands attention from global health organizations.

Spotlight

IMS Consulting Group

IMSCG is the leading global consulting firm focused exclusively on life sciences. Our clients range from the large pharmaceutical and biotech companies to entrepreneurial companies preparing for their first launch. We collaborate with our clients to make critical business decisions, build commercial excellence, and grow their businesses in an increasingly challenging environment.

Other Infographics
news image

Summary of Chloroquine and Hydroxychloroquine Drug-Drug Interactions

Infographic | April 7, 2020

COVID-19 is a rapidly emerging and devastating pandemic disease. Recently, chloroquine (CQ) and hydroxychloroquine (HCQ) have been suggested for possible off-label use for patients suffering from a more severe clinical course.

Read More
news image

Latest Improvement on Pharmanews to Serve You Better

Infographic | April 16, 2020

Poised to give our readers and advertisers better services in spite of the COVID19 pandemic, Pharmanews–your global health journal has continued to improve on its services in terms of healthcare information dissemination, by keeping readers abreast of latest development in public health, especially on how to stay safe from the novel Coronavirus, as well as expanding our reach to over 250,000 readers per month.

Read More
news image

Pharmaceutical industry and medicine

Infographic | March 12, 2022

Pharmaceutical industry and medicine vector infographics with drugs, pills, bottles and packages, text blocks and charts all around

Read More
news image

COVID-19 Summary as of March 13, 2020

Infographic | April 6, 2020

Biomedtracker and Trialtrove have a total of 307 clinical trials for the treatment of COVID-19. 152 initiated trials for the treatment of COVID-19. 155 Trials have been announced but have not yet begun recruitment.

Read More
news image

2021 global life sciences outlook

Infographic | August 24, 2021

The life sciences sector has played a pivotal role amid the COVID-19 pandemic. To cope with the global crisis, traditional competitors partnered to accelerate research and develop the fastest novel vaccine in the history. Governments, health systems, payers, retail pharmacies, and nonprofits are now working collaboratively with the sector to provide widespread distribution and administration.

Read More
news image

Cancer Drugs Bring in Most Pharma Revenue

Infographic | February 25, 2020

Worldwide cancer drug sales are already way ahead of those of other drugs and the revenue generated by them is expected to grow even larger by 2024. This is according to a report recently released by consultancy Evaluate, which analyses trends in the pharmaceutical sector. According to Evaluate's calculations, oncology drugs reached US$123.8 billion in sales in 2018, more than double that of the next item on the list, drugs treating diabetes with US$48.5 billion dollars in sales. By 2024, cancer drug sales are expected to almost double to US$236.6 billion dollars.

Read More

Spotlight

IMS Consulting Group

IMSCG is the leading global consulting firm focused exclusively on life sciences. Our clients range from the large pharmaceutical and biotech companies to entrepreneurial companies preparing for their first launch. We collaborate with our clients to make critical business decisions, build commercial excellence, and grow their businesses in an increasingly challenging environment.

Events